Effect of SCF in vitro stimulation on hemopoietic progenitor cells (HPC) from patients with myelodysplastic syndromes: Comparison with other growth factors.

被引：0
|
作者：
Novelli, EM [1 ]
Ruggieri, L [1 ]
Camba, I [1 ]
机构：
[1] IST SCI SAN RAFFAELE,MILAN,ITALY
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3560 / 3560
页数：1
相关论文
共 50 条
  • [31] CHANGES IN ERYTHROID PROGENITOR-CELL AND ACCESSORY CELL COMPARTMENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES DURING TREATMENT WITH ALL-TRANS-RETINOIC ACID AND HEMATOPOIETIC GROWTH-FACTORS
    MAURER, AB
    GANSER, A
    SEIPELT, G
    OTTMANN, OG
    MENTZEL, U
    GEISSLER, GR
    HOELZER, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (03) : 449 - 456
  • [32] Dendritic cells (DC) generated from hematopoietic progenitor cells express endothelial cell markers and can be converted into endothelial-like cells (ELC) in the presence of angiogenic growth factors.
    Pujol, BF
    Lucibello, FC
    Zuzarte, ML
    Müller, R
    Havemann, K
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S29 - S29
  • [33] THE IN VITRO EFFECTS OF 5-AZACITIDINE ON THE IMMUNOPHENOTYPE OF MONOCYTE-DERIVED DENDRITIC CELLS FROM PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES
    Tsai, Randy
    Fields, Hannah
    Zhang, Xinlian
    Ferrari, Valentina
    Park, Soo
    Bejar, Rafael
    Tanaka, Tiffany
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A712 - A712
  • [34] iPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulation
    Lopez-Caraballo, Lidia
    Martorell-Marugan, Jordi
    Carmona-Saez, Pedro
    Gonzalez-Munoz, Elena
    [J]. CELLS, 2020, 9 (08) : 1 - 21
  • [35] INVITRO GROWTH MODULATION BY L-ASCORBIC-ACID OF COLONY-FORMING CELLS FROM BONE-MARROW OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    PARK, CH
    KIMLER, BF
    BODENSTEINER, D
    LYNCH, SR
    HASSANEIN, RS
    [J]. CANCER RESEARCH, 1992, 52 (16) : 4458 - 4466
  • [36] Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro
    Valérie Soenen-Cornu
    Cristina Tourino
    Marie-Laure Bonnet
    Martine Guillier
    Stéphane Flamant
    Rami Kotb
    Alain Bernheim
    Jean-Henri Bourhis
    Claude Preudhomme
    Pierre Fenaux
    Ali G Turhan
    [J]. Oncogene, 2005, 24 : 2441 - 2448
  • [37] Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro
    Soenen-Cornu, V
    Tourino, C
    Bonnet, ML
    Guillier, M
    Flamant, S
    Kotb, R
    Bernheim, A
    Bourhis, JH
    Preudhomme, C
    Fenaux, P
    Turhan, AG
    [J]. ONCOGENE, 2005, 24 (15) : 2441 - 2448
  • [38] Prevalence of paroxysmal nocturnal hemoglobinuria (PNH) cells in patients with myelodysplastic syndromes (MDS), aplastic anemia (AA), or other bone marrow failure (BMF) syndromes: Interim results from the EXPLORE trial
    Galili, N.
    Ravandi, F.
    Palermo, G.
    Bubis, J.
    Illingworth, A.
    Castro-Malaspina, H.
    Raza, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Secretion of pro-survival and pro-angiogenic growth factors in vitro and in vivo by cardiac progenitor cells from human biopsies
    Chimenti, Isotta
    Smith, Rachel Ruckdeschel
    Leppo, Michelle K.
    Gerstenblith, Gary
    Giacomello, Alessandro
    Messina, Elisa
    Marban, Eduardo
    [J]. CIRCULATION RESEARCH, 2007, 101 (11) : 1209 - 1209
  • [40] Effect of BDNF and Other Potential Survival Factors in Models of In Vitro Oxidative Stress on Adult Spinal Cord-Derived Neural Stem/Progenitor Cells
    Hachem, Laureen D.
    Mothe, Andrea J.
    Tator, Charles H.
    [J]. BIORESEARCH OPEN ACCESS, 2015, 4 (01): : 146 - 159
12345